Breaking News

Tianyin Pharmaceutical Updates JV With Buchang Pharma

New GMP facility spurred discussions

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Tianyin Pharmaceutical Co., Inc. (TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), said that the discussions between itself and Buchang Pharma (www.buchang.com) have developed towards increasing the percentage of ownership by Buchang Pharma in the Tianyin-Buchang Alliance joint venture. The total registered capital for the joint venture is approximately $33 ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters